0030.Hk
The company operates in the Food & Drug Retailing industry, generating revenue primarily through the retail and distribution of food and drug products.
Business. The company operates in the Food & Drug Retailing industry, generating revenue primarily through the retail and distribution of food and drug products.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the Food & Drug Retailing industry, generating revenue primarily through the retail and distribution of food and drug products.
The company maintains a strong liquidity position, with cash and equivalents amounting to HKD 198,007,250, which represents 33.4% of total assets. The current ratio of 2.54 indicates a solid ability to meet short-term obligations. The price-to-book ratio of 5.91 suggests that the market values the company at a premium relative to its book value, while the price-to-tangible-book ratio is identical, indicating no significant intangible assets.
Profitability metrics show a return on equity (ROE) of 1.28% and a return on assets (ROA) of 0.77%, both of which are below the typical thresholds for high-performing firms in the retail sector. The operating margin is 0.90%, and the net profit margin is 0.41%, indicating that the company is generating modest returns on its operations.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification may expose the company to regional economic fluctuations and regulatory changes. The absence of segment-specific data limits the ability to assess the performance of different parts of the business.
The company's revenue growth trajectory is not clearly defined, as the available data does not provide a multi-year trend. However, the current fiscal year's revenue is HKD 1,108,176,540, and the company's market capitalization is HKD 2,117,413,501.63, suggesting a relatively stable but not rapidly growing business.
The company's risk profile is characterized by low liquidity and dilution risks. The debt-to-equity ratio of 0.02 indicates a conservative capital structure with minimal leverage. There are no immediate filing-based liquidity or dilution flags, and the company has not issued additional shares recently.
Recent events include the latest financial filing, which disclosed the company's revenue and net income for the most recent period. No significant changes in management, strategic direction, or major capital expenditures were reported in the latest filings. The company's earnings per share (EPS) for the last reported period was HKD 0.13, and the revenue was HKD 108,879,000.
- The company has a strong liquidity position with a current ratio of 2.54 and significant cash reserves.
- Profitability metrics are modest, with ROE and ROA below typical thresholds for the retail sector.
- The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification.
- The company maintains a conservative capital structure with a low debt-to-equity ratio of 0.02.
- There are no immediate liquidity or dilution risks, and the company's risk profile is generally low.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- 0030.HK Market data — financials · 2026-05-26
- YNBY International Ltd Market data — analyst estimates · 2026-05-26
Ownership & reference
Leadership
- Ming DongExecutive Chairman of the Board
- Ming TangChief Executive Officer, Executive Director
Insider activity
Short positioning
Geographic breakdown
Intel & risk
4 tracked-field change(s) detected vs prior analysis; max severity: medium.
- Dilution risk— → lowlow
- Liquidity risk— → lowlow
- Activity— → Food & Drug Retailingmedium
- Economic sector— → Consumer Non-Cyclicalsmedium